Isotretinoin-Induced Delusional Disorder, Somatic Subtype

المؤلفون المشاركون

Jensen, Katharine V.
Abba-Aji, Adam

المصدر

Case Reports in Dermatological Medicine

العدد

المجلد 2020، العدد 2020 (31 ديسمبر/كانون الأول 2020)، ص ص. 1-3، 3ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2020-07-26

دولة النشر

مصر

عدد الصفحات

3

التخصصات الرئيسية

الأمراض

الملخص EN

Isotretinoin, an active form of vitamin A, is the drug of last resort for the treatment of severe acne.

Depression, suicidal ideation, and psychosis are among the most well-documented psychiatric side effects.

Here, we report a case of isotretinoin-induced psychosis, which was diagnosed as delusional disorder somatic subtype, in a young male in the absence of any prodromal symptoms, previous psychiatric history, or family history of mental illness.

The onset of psychosis was in the context of a dosage increase from 40 mg/day to 80 mg/day.

Isotretinoin was discontinued, and the patient showed improvement on low-dose quetiapine.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Jensen, Katharine V.& Abba-Aji, Adam. 2020. Isotretinoin-Induced Delusional Disorder, Somatic Subtype. Case Reports in Dermatological Medicine،Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1146904

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Jensen, Katharine V.& Abba-Aji, Adam. Isotretinoin-Induced Delusional Disorder, Somatic Subtype. Case Reports in Dermatological Medicine No. 2020 (2020), pp.1-3.
https://search.emarefa.net/detail/BIM-1146904

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Jensen, Katharine V.& Abba-Aji, Adam. Isotretinoin-Induced Delusional Disorder, Somatic Subtype. Case Reports in Dermatological Medicine. 2020. Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1146904

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-1146904